UCB has announced positive new three-year data for its inflammatory disease drug Bimzelx (bimekizumab) in adults with active ...

Galderma has shared positive two-year data for its monoclonal antibody Nemluvio (nemolizumab) in moderate-to-severe atopic ...

Today, by contrast, the marketers I study complain of being swamped by data and confused by information overload. And when I ...

NewAmsterdam Pharma has shared promising Alzheimer’s disease (AD) biomarker data from a late-stage study of its ...

Results from the study’s open-label period, presented at this year’s European Renal Association Congress, showed that ...

Alnylam Pharmaceuticals’ Amvuttra (vutrisiran) has been approved by the European Commission (EC) to treat adults with ...

By combining different treatment options – especially those involving immuno-oncology (IO) – researchers aim to develop ...

Merck & Co – known as MSD outside the US and Canada – has announced that its respiratory syncytial virus (RSV) preventive ...

The American Diabetes Association’s 85th Scientific Sessions is almost here, and Medscape is ready to make an impact in the ...

The authorisation comes three months after the MHRA approved Johnson & Johnson’s Lazcluze (lazertinib), which is also ...

The PM (Pharmaceutical Marketing) Society is delighted to announce a new partnership with the CIM (Chartered Institute of ...

What does SAY’s healthcare communications crystal ball reveal for the coming year? We’ve looked at what we can expect to see ...